AMAG Pharma (AMAG) Misses Q2 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. JBLU
4. ANT
5. META
6. SSD
7. AGYS
8. PECO
9. AMKR
10. BX

Go back to AMAG Pharma (AMAG) Misses Q2 EPS by 21c

AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update

August 2, 2018 7:00 AM EDT

Achieved 12% revenue growth and record quarterly sales

Raising full year revenue and adjusted EBITDA guidance for pharmaceutical products

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the quarter ended June 30, 2018. The company announced the sale of Cord Blood Registry® (CBR®) in June 2018, which is currently expected to close in mid-August 2018. As a result of the pending sale, CBR is being classified as discontinued operations... More